Examining the “revisability” benefit of hip resurfacing arthroplasty
World Journal of Orthopedics · 18.06.2024 · 15 (6) · 554-559
DOI: 10.5312/wjo.v15.i6.554 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Orthopedics, online erschienen am 18.06.2024. Verfasst von Jose George und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States. josegrg2019@gmail.com. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Hip resurfacing arthroplasty (HRA) is an alternative to total hip arthroplasty (THA) that is typically reserved for young active patients because it preserves bone. However, the benefits of HRA only hold true if conversion THA after failed HRA provides acceptable outcomes. AIM To compare patient reported outcomes for conversion THA after HRA failure to primary THA. METHODS A retrospective review of 36 patients (37 hips) that underwent conversion THA for failed HRA between October 2006 and May 2019 by a single surgeon was performed. Patient reported outcomes [modified Harris Hip Score (mHHS), University of California Los Angeles (UCLA) activity score] were obtained via an email-based responder-anonymous survey. Outcomes were compared to normative data of a primary THA cohort with similar demographics. Subgroup analysis was performed comparing outcomes of conversion THA for adverse local tissue reaction (ALTR) vs all other causes for failure. RESULTS The study group had a lower mHHS than the control group (81.7 ± 13.8 vs 90.2 ± 11.6, P < 0.01); however, both groups had similar UCLA activity levels (7.5 ± 2.3 vs 7.2 ± 1.6, P = 0.51). Patients that underwent conversion for non-ATLR causes had similar mHHS (85.2 ± 11.5 vs 90.2 ± 11.6, P = 0.11) and higher UCLA activity levels (8.5 ± 1.8 vs 7.2 ± 1.6, P < 0.01) compared to the control group. Patients that underwent conversion for ATLR had worse mHHS (77.1 ± 14.5 vs 90.2 ± 11.6, P < 0.01) and UCLA activity levels (6.1 ± 2.3 vs 7.2 ± 1.6, P = 0.05) when compared to the control group. CONCLUSION Patient outcomes equivalent to primary THA can be achieved following HRA conversion to THA. However, inferior outcomes were demonstrated for ALTR-related HRA failure. Patient selection and perhaps further studies examining alternative HRA bearing surfaces should be considered.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States. josegrg2019@gmail.com.
- Department of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States.
Zitieren
APA
George, J., Taylor, A. J., & Schmalzried, T. P. (2024). Examining the “revisability” benefit of hip resurfacing arthroplasty. World Journal of Orthopedics, 15(6), 554-559. https://doi.org/10.5312/wjo.v15.i6.554
Vancouver
George J, Taylor AJ, Schmalzried TP. Examining the “revisability” benefit of hip resurfacing arthroplasty. World Journal of Orthopedics. 2024;15(6):554-559. doi:10.5312/wjo.v15.i6.554
BibTeX
@article{George2024,
author = {George, Jose and Taylor, Adam J and Schmalzried, Thomas P},
title = {Examining the “revisability” benefit of hip resurfacing arthroplasty},
journal = {World Journal of Orthopedics},
year = {2024},
volume = {15},
number = {6},
pages = {554--559},
doi = {10.5312/wjo.v15.i6.554}
}
EUVIMED